PTGS2 and cancer: It is not known whether COX-2 expression is a prognostic factor, independently of other known prognostic factors, including tumor features and molecular characteristics, such as stage (tumor, node, metastasis), differentiation, age, sex and weight loss, and data on cancer treatment are limited in our meta-analysis.